Konan, Japan

Mineo Takei

This inventor holds 3 USPTO granted patents. Top assignee: Zeria Pharmaceutical Co., Ltd.. Active years: 1998-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mineo Takei. Retrieved from https://idiyas.com/inventor/mineo-takei

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.6

ph-index = 2

Forward Citations = 14(Granted Patents)


Location History:

  • Osato-gun, JP (2001)
  • Konanmachi, JP (1998 - 2002)

Company Filing History:


Years Active: 1998-2002

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Mineo Takei

Introduction

Mineo Takei is a notable inventor based in Konan-machi, Japan. He has made significant contributions to the field of pharmaceuticals, holding a total of 3 patents. His work focuses on developing innovative compounds that have potential applications in drug development.

Latest Patents

Among his latest patents are the N-phenyl-N′-phenylpopylpiperazine derivatives and a process for their preparation. Additionally, he has developed 3-benzoylindole derivatives and drugs containing the same. The present invention is directed to 3-benzoylindole derivatives represented by a specific formula, showcasing his expertise in chemical synthesis and pharmaceutical applications.

Career Highlights

Mineo Takei is associated with Zeria Pharmaceutical Co., Ltd., where he has been instrumental in advancing research and development efforts. His innovative approach has led to the creation of valuable pharmaceutical compounds that contribute to the industry.

Collaborations

He has collaborated with notable colleagues such as Hiroki Sato and Eiichi Nagano, further enhancing the impact of his work in the pharmaceutical sector.

Conclusion

Mineo Takei's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence drug development and innovation in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…